Awards & Advancement

Cyberonics names Rohan Hoare COO, O'Neill D'Cruz CMO

Wednesday, April 30, 2014 03:42 PM

Cyberonics, a medical technology company, has promoted Rohan Hoare, Ph.D., to the newly created role of chief operating officer. Rohan will be responsible for the development, manufacturing, quality and commercial activities for the Epilepsy franchise. The company also announced that O'Neill F. D'Cruz, M.D. recently joined the company as chief medical officer.

More... »


Icon appoints Hugh Brady to board of directors

Wednesday, April 30, 2014 03:11 PM

CRO Icon has appointed Dr. Hugh Brady as a non-executive director on the board of directors.

More... »

Subscribe to The CenterWatch Monthly

Michael S. Gordon named medical director for cancer center trials at Scottsdale Healthcare

Friday, April 25, 2014 11:21 AM

Michael S. Gordon, M.D., has been named the new medical director for the Virginia G. Piper Cancer Center Clinical Trials program at Scottsdale Healthcare. Gordon will oversee the center's phase I clinical trials program. Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, a partnership with Translational Genomics Research Institute, is a clinical research site for phase I studies of new cancer drugs.

More... »

Michael Tansey joins PhESi as strategic partner

Thursday, April 24, 2014 11:14 AM

Michael Tansey, BSC, MB, ChB, M.D., FFPM, former chief medical officer of Pharmacia, has joined PhESi as a strategic partner.

More... »

PPD adds Bhooshi De Silva as senior vice president

Monday, April 21, 2014 10:40 AM

CRO Pharmaceutical Product Development (PPD) has added Bhooshi De Silva as senior vice president of corporate development and strategy to its executive leadership team. De Silva will focus on key strategic initiatives vital to supporting PPD’s growth and client success, including corporate development, strategy and mergers and acquisitions.

More... »

SMART Platforms Project names advisory committee

Friday, April 18, 2014 11:26 AM

The SMART (Substitutable Medical Apps & Reusable Technology) Platforms project at Boston Children's Hospital—which is developing technology to create an app-driven health information economy—has announced the formation of an advisory committee that will guide the project on strategy, technical approach and business development.

More... »

Ian Read becomes PhRMA board chairman; Ken Frazier, George Scangos on board

Friday, April 18, 2014 10:37 AM

Ian C. Read, chairman and CEO of Pfizer, was elected chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA). Read succeeds Robert J. Hugin, chairman and CEO of Celgene, as PhRMA's chairman. Also elected were Kenneth C. Frazier, chairman, president and CEO of Merck, as chairman-elect of the PhRMA board of directors, and George A. Scangos, Ph.D., CEO of Biogen Idec, as board treasurer.

More... »

Icon’s Firecrest training recognized by TransCelerate BioPharma

Monday, April 14, 2014 10:13 AM

Icon,a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has announced that its Firecrest training meets TransCelerate BioPharma’s minimum criteria for International Conference on Harmonization Good Clinical Practice (ICH/GCP) training.

More... »

Jon L. Hart named CEO of med fusion

Friday, April 11, 2014 01:23 PM

med fusion, an integrated, advanced laboratory and clinical trials service organization, has appointed Jon L. Hart CEO, effective March 31. This appointment is the next step in the organization’s continued drive towards becoming the clear leader in providing lab and clinical trial support to healthcare providers and biotech/pharmaceutical companies through a patient-centric support model.

More... »

MEI Pharma adds David Urso as senior VP of Corporate Development, General Counsel

Friday, April 11, 2014 01:12 PM

MEI Pharma, an oncology company focused on the clinical development of novel therapies for cancer, has appointed David Urso senior vice president of Corporate Development and General Counsel. Urso joins MEI Pharma with more than two decades of experience in the life science industry, most recently as chief operating officer and general counsel at Tioga Pharmaceuticals, a company he co-founded in 2005 as a principal at Forward Ventures.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 15

Cancer Treatment Centers of America chooses WCG as its exclusive IRB, sheds five local hospital IRBs

Five southern research groups form public-private network to help save time, money for clients with early-stage biologics

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs